Search
Cobamamide
go.drugbank.com/drugs/DB11191ApprovedNutraceuticalThe principal biochemical participants are two coenzyme forms of Vitamin B12 that are produced and activated in two separate cellular compartments: methylcobalamin in the cytosol and adenosylcobalamin … MeCbl is mainly involved along with folate in hematopoiesis and the growth of the brain during childhood.
Mixtures: EnLyte Extra-LNCategories: Enzymes and Coenzymes, Blood and Blood Forming OrgansVecabrutinib
go.drugbank.com/drugs/DB16657InvestigationalVecabrutinib is under investigation in clinical trial NCT03037645 (Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers).
MK-0533
go.drugbank.com/drugs/DB15242InvestigationalMK-0533 is under investigation in clinical trial NCT00543959 (Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)).
ATB-346
go.drugbank.com/drugs/DB15377InvestigationalATB-346 is under investigation in clinical trial NCT03220633 (Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects).
Plozalizumab
go.drugbank.com/drugs/DB12520InvestigationalPreclinical studies suggest that CCR2 plays an important role in the trafficking of monocytes and macrophages to sites of inflammation. … The recruitment of macrophages to the arterial wall is believed to be a critical step in the development of atherosclerosis.
Categories: Amino Acids, Peptides, and ProteinsNickel sulfate
go.drugbank.com/drugs/DB14180ApprovedNickel sulfate is used in allergenic testing.
Mixtures: Multivitamins and Minerals Tablets, Milltrium Senior Vitamin and Mineral SupplementCategories: Compounds used in a research, industrial, or household settingJoint Diseases
go.drugbank.com/conditions/DBCOND0028263Drugs: ThymolSynonyms: Osteoarthritis and allied disordersMK-0873
go.drugbank.com/drugs/DB13029InvestigationalMK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis.
Albinterferon Alfa-2B
go.drugbank.com/drugs/DB05396InvestigationalIn response to an FDA ruling, Novartis and Human Genome Sciences announced on October 5, 2010 that they ceased development of the drug. … The drug was under investigation as an alternative to pegylated IFN-α-2a for the treatment of hepatitis C.
Categories: Interferon Type I, Amino Acids, Peptides, and ProteinsSynonyms: alb-IFNOdronextamab
go.drugbank.com/drugs/DB16684ApprovedInvestigational[A254187,A254197] Preliminary studies have shown that in patients with R/R NHL, the use of odronextamab does not lead to the development of neurologic toxicity; however, it can lead to the development … [A254187] In December 2020, the FDA placed a partial clinical hold and requested the drug developer, Regeneron Pharmaceuticals, to amend clinical protocols to reduce the incidence of CRS.
Categories: Antineoplastic and Immunomodulating Agents, Monoclonal antibodies and antibody drug conjugates